Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
ICE brings futures trading to London’s $190 billion-a-day physical gold market

ICE brings futures trading to London’s $190 billion-a-day physical gold market

KitcoKitco2026/10/06 15:18

(Kitco News) – The world’s largest physical gold trading market now has new futures contracts run by the world’s largest precious metals futures exchange.

This week, the Intercontinental Exchange (ICE) – owner of the New York Stock Exchange –launched exchange-traded precious metal futures trading in London. The contracts are directly linked to London's daily gold price auctions, and the exchange has also launched futures contracts for silver, platinum and palladium. The new ICE contracts give market participants an exchange-based means to trade precious metals price exposure from London.

London’s physical gold trading dwarfs that of any other global market, with daily over-the-counter transactions in the area of $190 billion, while the city's vaults hold approximately $1.4 trillion in gold bullion. Unlike New York, which has had well-established gold futures trading, London has not had a major gold futures market in many years despite its dominant position in the physical bullion market.

Previous attempts to establish gold futures trading in London did not last. The London Gold Futures Market was launched in 1982 but shut down only three years later after failing to attract a critical mass of trading activity. Then in 2017, the London Metal Exchange launched their own gold futures, but the contract was eventually discontinued in 2022.

ICE's latest attempt leverages its existing role in London's physical metals market, as the exchange already operates the daily auctions that set the benchmark prices for gold, silver, platinum and palladium.

See live precious metals prices for gold, silver, platinum and palladium — in USD, CAD and 12 more currencies. 

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

VWO ETF Closes Flat

This article was automatically generated using Dow Jones technology. Shares of Vanguard FTSE Emerging Markets ETF were flat at $60.62 Tuesday on what proved to be an overall favorable trading session for the U.S. stock market, with the S&P 500 Index rising 0.6% to 7,818.93. This was the fund's third consecutive day of gains. The ETF's shares closed 1.5% below the 52-week high of $61.53 seen on September 4, 2026. Trading volume was 4,661,177, compared to the 65-day average trading volume of 7,016,590. As of October 5, the fund's net asset value totaled $60.76 per share. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 06, 2026 16:37 ET (20:37 GMT)

Dow Jones•2026/10/06 20:37

Novavax Inc. Stock Slides 9.9%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Novavax Inc. shed 9.9% to $11.32 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 27,599.79 and the Dow Jones Industrial Average rising 0.5% to 51,521.28. Novavax Inc. closed 15.4% below its 52-week high of $13.39, which the company achieved on October 5th. The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.7% to $254.78, Pfizer Inc. rose 0.3% to $27.50, and Merck & Co. Inc. rose 1.72% to $141.94. Trading volume totaled 19.3 million, compared to the 50-day average of 5.3 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 06, 2026 16:33 ET (20:33 GMT)

Dow Jones•2026/10/06 20:33
Novavax Inc. Stock Slides 9.9%, Underperforms Peers

Evogene announces special shareholder meeting

Evogene will hold a special general meeting of shareholders in Rehovot, Israel on Nov. 10, 2026. Shareholders will vote on electing Oz Adler and Dr. Adi Zuloff-Shani to the board. Ballots will also cover the election of Itay Maroz and Shahar Zadok, subject to approval of a cooperation agreement. The meeting will also vote on a cooperation agreement between Evogene and L.I.A. Pure Capital and Invest-Pro Shukai Hon. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evogene Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-004722), on October 06, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/06 20:00